Scott Marshall

U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease

Julia Scarisbrick, Peter C. Taylor, Udo Holtick et al. · British Journal of Dermatology · 2008 · 174 citations

Medicine, Hematology, Oncology +13

Molecular MRD is strongly prognostic in patients with <i>NPM1</i>-mutated AML receiving venetoclax-based nonintensive therapy

Jad Othman, Ing Soo Tiong, Jenny O’Nions et al. · Blood · 2023 · 65 citations · Full text

Medicine, Hematology, Oncology +14

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations

Nigel H. Russell, Charlotte S. Wilhelm-Benartzi, Jad Othman et al. · Journal of Clinical Oncology · 2024 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Impact of Psoralen/UVA-Treatment on Survival, Activation, and Immunostimulatory Capacity of Monocyte-Derived Dendritic Cells

Udo Holtick, Scott Marshall, Xiaonong Wang et al. · Transplantation · 2008 · 37 citations

Life Sciences, Cell Biology, Immunology +17

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL

Dena Howard, Talha Munir, Lucy McParland et al. · Leukemia · 2017 · 34 citations · Full text

Medicine, Pharmacotherapy, Clinical Pharmacology +2